tiprankstipranks
Trending News
More News >
CompuGroup Medical SE (GB:0MSD)
LSE:0MSD
UK Market

CompuGroup Medical (0MSD) Ratios

Compare
3 Followers

CompuGroup Medical Ratios

GB:0MSD's free cash flow for Q1 2025 was €0.84. For the 2025 fiscal year, GB:0MSD's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.12 1.07 1.12 0.93 1.06
Quick Ratio
1.04 1.01 1.04 0.88 1.00
Cash Ratio
0.24 0.19 0.24 0.27 0.26
Solvency Ratio
0.15 0.13 0.15 0.15 0.16
Operating Cash Flow Ratio
0.39 0.52 0.39 0.41 0.52
Short-Term Operating Cash Flow Coverage
4.30 28.72 4.30 1.70 3.77
Net Current Asset Value
€ -849.81M€ -860.84M€ -849.81M€ -807.75M€ -618.72M
Leverage Ratios
Debt-to-Assets Ratio
0.40 0.40 0.40 0.41 0.35
Debt-to-Equity Ratio
1.17 1.15 1.17 1.21 0.87
Debt-to-Capital Ratio
0.54 0.53 0.54 0.55 0.46
Long-Term Debt-to-Capital Ratio
0.51 0.51 0.51 0.49 0.42
Financial Leverage Ratio
2.89 2.85 2.89 2.93 2.45
Debt Service Coverage Ratio
4.64 6.21 4.64 1.83 3.49
Interest Coverage Ratio
13.78 5.05 13.78 20.13 22.05
Debt to Market Cap
0.39 0.36 0.39 0.18 0.12
Interest Debt Per Share
15.23 15.15 15.23 14.27 10.42
Net Debt to EBITDA
3.01 3.25 3.01 2.93 2.47
Profitability Margins
Gross Profit Margin
84.81%84.62%84.81%84.97%85.15%
EBIT Margin
10.26%8.17%10.26%10.07%13.95%
EBITDA Margin
20.48%18.17%20.48%21.13%23.24%
Operating Profit Margin
11.12%10.35%11.12%10.60%14.29%
Pretax Profit Margin
9.45%6.12%9.45%9.55%13.19%
Net Profit Margin
6.50%3.87%6.50%6.73%8.74%
Continuous Operations Profit Margin
6.57%3.95%6.57%6.73%8.88%
Net Income Per EBT
68.73%63.18%68.73%70.47%66.28%
EBT Per EBIT
85.04%59.12%85.04%90.05%92.28%
Return on Assets (ROA)
3.78%2.42%3.78%3.85%4.67%
Return on Equity (ROE)
10.92%6.88%10.92%11.27%11.46%
Return on Capital Employed (ROCE)
8.01%7.92%8.01%7.81%9.38%
Return on Invested Capital (ROIC)
5.37%5.02%5.37%5.08%5.98%
Return on Tangible Assets
11.28%7.78%11.28%11.96%15.32%
Earnings Yield
3.91%2.31%3.91%1.85%1.73%
Efficiency Ratios
Receivables Turnover
5.09 5.63 5.09 5.62 -837.26K
Payables Turnover
1.55 2.22 1.55 1.65 1.93
Inventory Turnover
5.83 9.67 5.83 7.47 6.85
Fixed Asset Turnover
7.02 7.17 7.02 6.49 6.14
Asset Turnover
0.58 0.63 0.58 0.57 0.53
Working Capital Turnover Ratio
127.18 34.76 127.18 -205.25 117.89
Cash Conversion Cycle
-100.95 -61.82 -100.95 -106.82 -136.15
Days of Sales Outstanding
71.68 64.87 71.68 64.99 >-0.01
Days of Inventory Outstanding
62.62 37.74 62.62 48.88 53.32
Days of Payables Outstanding
235.26 164.43 235.26 220.69 189.46
Operating Cycle
134.31 102.61 134.31 113.87 53.32
Cash Flow Ratios
Operating Cash Flow Per Share
2.78 3.44 2.78 3.16 2.79
Free Cash Flow Per Share
1.23 1.99 1.23 1.68 1.75
CapEx Per Share
1.55 1.44 1.55 1.48 1.04
Free Cash Flow to Operating Cash Flow
0.44 0.58 0.44 0.53 0.63
Dividend Paid and CapEx Coverage Ratio
1.35 1.77 1.35 1.59 1.88
Capital Expenditure Coverage Ratio
1.79 2.38 1.79 2.13 2.69
Operating Cash Flow Coverage Ratio
0.18 0.23 0.18 0.22 0.27
Operating Cash Flow to Sales Ratio
0.13 0.15 0.13 0.16 0.18
Free Cash Flow Yield
3.40%5.25%3.40%2.36%2.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.60 43.23 25.60 53.98 57.70
Price-to-Sales (P/S) Ratio
1.66 1.67 1.66 3.63 5.04
Price-to-Book (P/B) Ratio
2.79 2.97 2.79 6.08 6.61
Price-to-Free Cash Flow (P/FCF) Ratio
29.37 19.06 29.37 42.42 44.83
Price-to-Operating Cash Flow Ratio
12.96 11.06 12.96 22.53 28.17
Price-to-Earnings Growth (PEG) Ratio
3.75 -1.15 3.75 -18.35 0.00
Price-to-Fair Value
2.79 2.97 2.79 6.08 6.61
Enterprise Value Multiple
11.13 12.45 11.13 20.11 24.18
Enterprise Value
2.58B 2.69B 2.58B 4.36B 4.70B
EV to EBITDA
11.13 12.45 11.13 20.11 24.18
EV to Sales
2.28 2.26 2.28 4.25 5.62
EV to Free Cash Flow
40.25 25.81 40.25 49.64 49.93
EV to Operating Cash Flow
17.76 14.97 17.76 26.36 31.37
Tangible Book Value Per Share
-11.87 -12.26 -11.87 -11.50 -8.36
Shareholders’ Equity Per Share
12.87 12.78 12.87 11.70 11.89
Tax and Other Ratios
Effective Tax Rate
0.31 0.36 0.31 0.29 0.34
Revenue Per Share
21.63 22.74 21.63 19.59 15.58
Net Income Per Share
1.41 0.88 1.41 1.32 1.36
Tax Burden
0.69 0.63 0.69 0.70 0.66
Interest Burden
0.92 0.75 0.92 0.95 0.95
Research & Development to Revenue
0.09 0.00 0.09 0.12 0.10
SG&A to Revenue
0.03 0.02 0.03 0.03 0.03
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 <0.01
Income Quality
1.96 3.83 1.96 2.39 2.04
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis